Clinical trial
Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary…
NCT00190996 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00190996 |
|---|---|
| Title | Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence |
| Official title | The Safety and Effectiveness of Duloxetine Compared With Placebo and Its Long-Term Safety and Efficacy in the Treatment of Predominant Stress Urinary Incontinence |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Stress |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride, placebo |
| Enrollment | 2,765 |
| Start date | Jan 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: